Martin Shkreli faces FTC contempt demand in drug case
Martin Shkreli, former chief government officer of Turing Prescription drugs AG, heart, pauses whereas communicate to members of the media together with his legal professional Benjamin Brafman, proper, outdoors federal court docket within the Brooklyn borough of New York, U.S., on Friday, Aug. 4, 2017.
Peter Foley | Bloomberg | Getty Photos
The Federal Commerce Fee on Friday requested a choose to carry infamous “pharma bro” Martin Shkreli in contempt of court docket for forming a brand new drug firm in violation of a ban on the convicted fraudster from working within the prescription drugs trade.
Shkreli, who was launched from jail final yr, had been banned “for all times from straight or not directly
taking part in any method within the pharmaceutical trade” on account of an FTC antitrust lawsuit towards him and a previous drug firm that he based.
The FTC, in its Manhattan federal court docket submitting, famous that Shkreli in July introduced the formation of a brand new firm, Druglike, “that seems to be concerned within the drug trade.”
The company mentioned that motion, in addition to Shkreli’s failure to pay his practically $25 million share of a $64.6 million judgment he owes within the lawsuit, recommend that he’s violating the court docket’s orders within the case.
That is breaking information. Please examine again for updates.